Pharmaceutical News

RSS

Affordable drug found to be effective in treating seriously ill COVID-19 patients

A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King's College London.

29 Sep 2025

Clinical trial disproves claims that antioxidant supplement boosts male fertility

A large Dutch randomized clinical trial (SUMMER) found that a widely marketed antioxidant supplement (Impryl) did not improve ongoing pregnancy rates in men seeking fertility care. Instead, pregnancy success was significantly lower in the critical 4–6 month treatment window, raising safety concerns.

28 Sep 2025

Essential oil compounds from Plectranthus neochilus show strong antidiabetic potential

A groundbreaking study published in the journal Current Pharmaceutical Analysis has uncovered the potential of essential oil compounds from the Plectranthus neochilus plant to serve as effective antidiabetic agents.

26 Sep 2025

Off-label drug helps one boy with autism speak, parents say. But experts want more data.

Caroline Connor's concerns about her son's development began around his 1st birthday, when she noticed he wasn't talking or using any words. Their pediatrician didn't seem worried, but the speech delay persisted. At 2½, Mason was diagnosed with autism.

26 Sep 2025

Antidepressant fluoxetine alters brain energy use and boosts neural plasticity

A new study shows that the widely used antidepressant fluoxetine does more than boost serotonin levels: it changes how brain cells manage their energy and rebuild their connections, potentially helping the brain "loosen up" and adapt during depression treatment.

25 Sep 2025

Analysis shows potential impact of deep NIH budget cuts on future drug development

Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid leukemia.

25 Sep 2025

KFF Health News' 'What the Health?': Public health further politicized under the threat of more firings

In a highly unusual White House news conference this week, President Donald Trump — without evidence — boldly blamed the painkiller Tylenol and a string of childhood vaccines for causing a recent rise in autism.

25 Sep 2025

FAU study explores how a new drug may help treat PTSD and its common companions

About 12 million adults in the United States are affected by PTSD, impacting between 4% and 8% of the adult population – and up to 30% of military personnel and veterans.

24 Sep 2025

Trump claims ‘no downside’ to avoiding Tylenol during pregnancy. He’s wrong.

Obstetricians have long advised their pregnant patients that Tylenol is the safest option to reduce fever or pain. President Donald Trump stood before a national audience on Sept. 22 and contradicted that.

24 Sep 2025

Improving medication access in primary care with pharmacy technician support

This study examined whether adding pharmacy technicians to primary care teams relieved clinicians and nurses of medication-access tasks and improved perceptions of burden, quality of care and patient access.

23 Sep 2025

‘Sick to my stomach’: Trump distorts facts on autism, tylenol, and vaccines, scientists say

Ann Bauer, a researcher who studies Tylenol and autism, felt queasy with anxiety in the weeks leading up to the White House's much-anticipated autism announcement.

22 Sep 2025

New quintuple agonist shows promise for treating obesity and type 2 diabetes

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists (dual agonists such tirzepatide).

21 Sep 2025

Why universal COVID-19 vaccine guidance offers stronger protection than high-risk-only policies

The US Scenario Modeling Hub’s nine-team ensemble projected COVID-19 hospitalizations and deaths for April 2024 to April 2025 under six policy and immune-escape scenarios. Burden was similar to the prior year, with universal vaccination recommendations averting more outcomes than high-risk-only guidance, especially for adults aged 65 years and older.

21 Sep 2025

Survey reveals why some people turn to unregulated cannabis to treat medical conditions

Use of medical cannabis has been on the rise since it first became available to Utah patients in 2020. A medical cannabis card, which can be prescribed for difficult-to-treat conditions including PTSD and chronic pain, allows a patient to access licensed cannabis products in designated pharmacies.

19 Sep 2025

New findings support low-dose ATG to delay progression of type 1 diabetes

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

19 Sep 2025

Study reveals early nicotinamide use reduces risk of aggressive skin cancers

A large U.S. Department of Veterans Affairs cohort study found that Nicotinamide use was associated with a 14% lower risk of new keratinocyte skin cancers, driven by a 22% reduction in cSCC and no reduction in BCC. The strongest benefit (56% lower risk) appeared when nicotinamide was started after a patient’s first skin cancer, with diminishing returns after multiple cancers.

18 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

Mobile app improves reporting of suspected adverse drug reactions in Uganda

Results from a ground-breaking new trial published in The Lancet Global Health show that a mobile application, Med Safety, improved the reporting of suspected adverse drug reactions (ADRs) by healthcare workers in Uganda.

18 Sep 2025

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown.

17 Sep 2025

University of Maine team develops sustainable method to cut drug production costs

One of the main factors driving prices in pharmaceuticals, such as cholesterol-lowering drugs and antibiotics, is the cost of production and materials.

17 Sep 2025

Pharmaceutical News

Affordable drug found to be effective in treating seriously ill COVID-19 patients

Clinical trial disproves claims that antioxidant supplement boosts male fertility

Essential oil compounds from Plectranthus neochilus show strong antidiabetic potential

Off-label drug helps one boy with autism speak, parents say. But experts want more data.

Antidepressant fluoxetine alters brain energy use and boosts neural plasticity

Analysis shows potential impact of deep NIH budget cuts on future drug development

KFF Health News' 'What the Health?': Public health further politicized under the threat of more firings

FAU study explores how a new drug may help treat PTSD and its common companions

Trump claims ‘no downside’ to avoiding Tylenol during pregnancy. He’s wrong.

Improving medication access in primary care with pharmacy technician support

‘Sick to my stomach’: Trump distorts facts on autism, tylenol, and vaccines, scientists say

New quintuple agonist shows promise for treating obesity and type 2 diabetes

Why universal COVID-19 vaccine guidance offers stronger protection than high-risk-only policies

Survey reveals why some people turn to unregulated cannabis to treat medical conditions

New findings support low-dose ATG to delay progression of type 1 diabetes

Study reveals early nicotinamide use reduces risk of aggressive skin cancers

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

Mobile app improves reporting of suspected adverse drug reactions in Uganda

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

University of Maine team develops sustainable method to cut drug production costs

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News